相关实验视频
Updated: Sep 19, 2025

16:31
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
25.0K
对用于目标导向流体治疗的晶体液体的血体积反应的减弱
Robert G Hahn1, Terry O'Brien2
1Karolinska Institutet at Danderyds Hospital (KIDS), Stockholm, Sweden. robert.hahn@ki.se.
Annals of intensive care
|June 19, 2025
概括
重复出现的晶体流体球体显示出血体积减小的效应,这可能会阻碍精确的流体响应性评估. 然而,体液不会表现出这种衰减,提供更一致的反应.
科学领域:
- 麻醉学 麻醉学
- 关键护理医学 关键护理医学
- 药理动力学 药理动力学
背景情况:
- 目标导向的流体疗法依赖于液体球体来优化心脏预负荷.
- 目前的实践假定每次流体大注血体积都会持续增加.
- 这项研究调查了这种假设对晶体和体液体的有效性.
研究的目的:
- 模拟和比较血体积对多次玻尿酸和合体流体注射的反应.
- 评估液体玻尿酸重复对心脏预负荷的影响.
- 评估流体响应评估在目标导向流体治疗中的可靠性.
主要方法:
- 对103名麻醉患者的晶体液体血体积动力学模拟.
- 用于合物 (基乙烯粉) 流体参数的文献数据.
- 模拟了三个玻璃注射 (晶体4毫升/千克;合体2-4毫升/千克),分隔5分钟.
主要成果:
- 结晶体液体在重复注射时显著减弱了血体积反应 (51%和36%的第一次注射效应).
- 尽管使用了输注前策略 (常速输注) 或Trendelenburg定位,但衰减仍然存在.
- 体液输注没有表现出这种衰减效应.
结论:
- 重复的晶体螺栓导致血体积扩张的减少,质疑它们对一致的预加载增强的有用性.
- 这种减弱可能会损害精确的流体响应诊断.
- 与水晶体相比,体液具有更可预测的血体积反应.
相关概念视频
Regulation of Water Intake
1.4K
Osmolality refers to the number of solute particles per kilogram of solvent in a solution. Plasma osmolality specifically indicates the total number of solute particles per kilogram of water in blood plasma. This value reflects the body's hydration status and is tightly regulated through mechanisms controlling water intake and output. While water consumption is a conscious decision, the body has intrinsic regulatory systems to maintain fluid balance. Dehydration, a state of water deficit...
1.4K
Heart Failure Drugs: Diuretics
505
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
505
Continuous Renal Replacement Therapy
156
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
156
Acute Kidney Injury VI: Nursing Management
69
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
69
Hormonal Regulation of Blood Pressure
3.2K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.2K
Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34

